Endoclear Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9M

Endoclear General Information

Description

Developer of novel tools designed to address unmet and urgent needs of patients, caregivers and hospitals in the field of respiratory management. The company's product removes secretions, biofilm and bacteria from the ventilated patient's endotracheal tubes, enabling hospitals with safer airway management system to improve patients outcome at a lower hospital cost.

Contact Information

Website
www.endoclearllc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2400 Camino Ramon
  • Suite 106
  • San Ramon, CA 94583
  • United States
Primary Industry
Other Devices and Supplies
Acquirer
Avanos Medical
Corporate Office
  • 2400 Camino Ramon
  • Suite 106
  • San Ramon, CA 94583
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endoclear Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 19-Sep-2019 $9M Completed Generating Revenue
3. Early Stage VC 22-May-2014 Completed Startup
2. Early Stage VC 20-Oct-2011 $2.4M $4.35M Completed Startup
1. Early Stage VC 12-Aug-2011 $1.95M $1.95M Completed Startup
To view Endoclear’s complete valuation and funding history, request access »

Endoclear Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Endoclear Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3050868-A1 Artificial airway management devices, systems and methods Pending 30-Dec-2016
US-20160256646-A1 Systems and methods for selectively blocking respiratory air flow Inactive 07-Oct-2013
EP-3055012-B1 Systems for selectively blocking respiratory air flow Active 07-Oct-2013
EP-3055012-A4 Systems and methods for selectively blocking respiratory air flow Active 07-Oct-2013
EP-3055012-A1 Systems and methods for selectively blocking respiratory air flow Active 07-Oct-2013 A61M16/0404
To view Endoclear’s complete patent history, request access »

Endoclear Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brenneck Partners Venture Capital Minority
To view Endoclear’s complete investors history, request access »

Ready to get started?

Request a free trial

Endoclear FAQs

  • When was Endoclear founded?

    Endoclear was founded in 2009.

  • Where is Endoclear headquartered?

    Endoclear is headquartered in San Ramon, CA.

  • What industry is Endoclear in?

    Endoclear’s primary industry is Other Devices and Supplies.

  • Is Endoclear a private or public company?

    Endoclear is a Private company.

  • What is the current valuation of Endoclear?

    The current valuation of Endoclear is .

  • What is Endoclear’s current revenue?

    The current revenue for Endoclear is .

  • How much funding has Endoclear raised over time?

    Endoclear has raised $5.13M.

  • Who are Endoclear’s investors?

    Brenneck Partners has invested in Endoclear.

  • When was Endoclear acquired?

    Endoclear was acquired on 19-Sep-2019.

  • Who acquired Endoclear?

    Endoclear was acquired by Avanos Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »